Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Show more
Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ), a social innovation platform dedicated to accelerating promising health innovations, announced today that its acquisition target, Evofem...
Evofem Secures Investor Support for Proposed Merger through Voting Agreements PR Newswire SAN DIEGO, Nov. 6, 2024 SAN DIEGO, Nov. 6, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM...
This firm’s treatment for a disfiguring skin infection has demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies, and shares are holding their own despite today's To...
Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target...
Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for...
Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ), a social innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A...
Aditxt, Inc. (βAditxtβ or the βCompanyβ) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced the appointment of Sylvia Hermina to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1139 | -19.3050847458 | 0.59 | 0.59 | 0.4529 | 4117748 | 0.54316249 | CS |
4 | -0.8539 | -64.2030075188 | 1.33 | 1.8599 | 0.4529 | 3781625 | 0.90231914 | CS |
12 | -44.3239 | -98.9372767857 | 44.8 | 46.8 | 0.4529 | 3965683 | 4.01842257 | CS |
26 | -93.1239 | -99.4913461538 | 93.6 | 108.8 | 0.4529 | 3028168 | 26.10526869 | CS |
52 | -268.3239 | -99.8228794643 | 268.8 | 380 | 0.4529 | 1960499 | 67.03631765 | CS |
156 | -3263.5239 | -99.9854136029 | 3264 | 45584 | 0.4529 | 2204628 | 1055.71391598 | CS |
260 | -8447.5239 | -99.9943643466 | 8448 | 45584 | 0.4529 | 2296751 | 2462.29143307 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.